BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.
Business Of Biotech
00:00
Sangamon - What's Your Modus Operandi?
We have four things in the clinic at the moment with Pfizer. We're in phase three for human fillet and Pfizer doing a great job. The patients are feeling better. People who've been on the ERT for years are sweating again. If CAR T-RAGs work what what it does is it takes you into type 1 diabetes multiple sclerosis inflammatory bowel disease, that's exciting. And then we have the first-ever T-RAG patients so we've those two patients where we've put in a CAR T-rag in renal transplant. That's going as well as a study I've ever run is going. There's now 15 T-RAG companies nine CAR T-
Transcript
Play full episode
